ConductScience.org, home

Gene · 5698

Papers4,120

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1,021 to 1,040 of 4,120

Download this page as JSON
TitleJournalYearPMIDFound bySource
A STING inhibitor suppresses EBV-induced B cell transformation and lymphomagenesis.Cancer Sci202134609775PubTator, text miningPubMed
Epstein-Barr Virus in the Development of Colorectal Cancer (Review).Sovrem Tekhnologii Med202134603767PubTator, text miningPubMed
Emerging Place of JAK Inhibitors in the Treatment of Inborn Errors of Immunity.Front Immunol202134603291PubTator, text miningPubMed
Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers.Blood Adv202134592752PubTator, text miningPubMed
An efficient method to identify virus-specific TCRs for TCR-T cell immunotherapy against virus-associated malignancies.BMC Immunol202134583647PubTator, text miningPubMed
Clonal Evolution of Multiple Myeloma-Clinical and Diagnostic Implications.Diagnostics (Basel)202134573876PubTator, text miningPubMed
Transcriptomics Underlying Pulmonary Ozone Pathogenesis Regulated by Inflammatory Mediators in Mice.Antioxidants (Basel)202134573120PubTator, text miningPubMed
Stress-Induced Epstein-Barr Virus Reactivation.Biomolecules202134572593PubTator, text miningPubMed
Out of Control: The Role of the Ubiquitin Proteasome System in Skeletal Muscle during Inflammation.Biomolecules202134572540PubTator, text miningPubMed
Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer.Cells202134572028PubTator, text miningPubMed
The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment.Front Oncol202134568077PubTator, text miningPubMed
A comprehensive analysis of genetic diversity of EBV reveals potential high-risk subtypes associated with nasopharyngeal carcinoma in China.Virus Evol202134567789PubTator, text miningPubMed
Metabolic Reprogramming and Immune Evasion in Nasopharyngeal Carcinoma.Front Immunol202134566954PubTator, text miningPubMed
Systems-Level Proteomics Evaluation of Microglia Response to Tumor-Supportive Anti-Inflammatory Cytokines.Front Immunol202134566949PubTator, text miningPubMed
Expression and clinical implications of basic leucine zipper ATF-like transcription factor 2 in breast cancer.BMC Cancer202134565331PubTator, text miningPubMed
Oncological Properties of Intravenous Leiomyomatosis: Involvement of Mesenchymal Tumor Stem-Like Cells.Curr Issues Mol Biol202134563053PubTator, text miningPubMed
Prognostic Factors for Overall Survival in Nasopharyngeal Cancer and Implication for TNM Staging by UICC: A Systematic Review of the Literature.Front Oncol202134540670PubTator, text miningPubMed
Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades.Front Immunol202134539626PubTator, text miningPubMed
Identifying the lungs as a susceptible site for allele-specific regulatory changes associated with type 1 diabetes risk.Commun Biol202134521982PubTator, text miningPubMed
Deconvolution of multiplexed transcriptional responses to wood smoke particles defines rapid aryl hydrocarbon receptor signaling dynamics.J Biol Chem202134520756PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/5698/papers?page=52